Xin Weng

Years Active: 2022-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yunyi Xu, Miao Xu, Xinglan Li, Xin Weng, Zhengzheng Su, Mengni Zhang, Junya Tan, Hao Zeng, Xun Li, Ling Nie, Jing Gong, Ni Chen, Xueqin Chen, Qiao Zhou
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression. The Prostate 83 (5) (2022)
Yunyi Xu, Miao Xu, Xinglan Li, Xin Weng, Zhengzheng Su, Mengni Zhang, Junya Tan, Hao Zeng, Xun Li, Ling Nie, Jing Gong, Ni Chen, Xueqin Chen, Qiao Zhou
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression. The Prostate (2022)
Yunyi Xu, Miao Xu, Xinglan Li, Xin Weng, Zhengzheng Su, Mengni Zhang, Junya Tan, Hao Zeng, Xun Li, Ling Nie, Jing Gong, Ni Chen, Xueqin Chen, Qiao Zhou
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression. The Prostate 83 (5) (2022)
Yunyi Xu, Miao Xu, Xinglan Li, Xin Weng, Zhengzheng Su, Mengni Zhang, Junya Tan, Hao Zeng, Xun Li, Ling Nie, Jing Gong, Ni Chen, Xueqin Chen, Qiao Zhou
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression. The Prostate 83 (5) (2022)

Xin Weng.css-eqlu8i{font-size:small;padding-left:4px;}